Uninvestigated dyspepsia and its related factors in an Iranian community

Saudi Medical Journal

Volumn 30, Issue 3, 2009, Pages 397-402

  Barzkar, Mosayeb ^a   Pourhoseingholi, Mohamad A ^a   Habibi, Manijeh ^a   Moghimi Dehkordi, Bijan ^a   Safaee, Azadeh ^a   Pourhoseingholi, Asma ^a   Khalafii, Abdolrasool ^a   Zali, Mohammad R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMMUNITY; DEPRESSION; DYSPEPSIA; EDUCATION; EPIGASTRIC FULLNESS; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERVIEW; IRAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SELF REPORT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DYSPEPSIA; EDUCATIONAL STATUS; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; OBESITY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS;

EID: 67649219648     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management. J Gastroenterol 2006; 101: S644-S653.
2. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145-160.
3. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 1992; 102: 1259-1268.
4. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-1822.
5. Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol 2001; 20: 103-106.
6. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: A population-based study. N Z Med J 2000; 113: 178-181.
7. Westbrook JI, McIntosh JH, Talley NJ, The impact of dyspepsia definition on prevalence estimates: Considerations for future researchers. Scand J Gastroenterol 2000; 35: 227-233.
8. The Newcastle Guideline Development and Research Unit. Dyspepsia: managing adults in primary care. London (UK): National Institute of Clinical Excellence; 2004.
9. Veldhuyzen van Zanten SJ, Flook N, Chiba N, Armstrong D, Barkun A, Bradette M, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ 2000; 162 (12 Suppl): S3-S23.
10. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN, et al. Functional gastroduodenal disorders. Gut 1999; Suppl 2: II37-I1142.
11. Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut 2002; Suppl 4: Iv10-iv12.
12. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-181.
13. homson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment - Promp Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003; 17: 1481-1491.
14. Maconi G, Tosetti C, Stanghellini V, Bianchi Porro G, Corinaldesi R. Dyspeptic symptoms in primary care. An observational study in general practice. Eur J Gatroenterol Hepatol 2002; 14: 985-990.
15. Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Impact of functional gastrointestinal disorders on health-related quality of life: A population-based case-control study. Aliment Pharmacol Ther 2004; 19: 233-242.
16. Rezailashkajani M, Roshandel D, Shafaee S, Zali MR. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran. Dig Liver Dis 2008; 40: 412-417.
17. Jones RH. Approaches to uninvestigated dyspepsia. Gut 2002; 50 (Suppl 4); Iv51-Iv55.
18. McQuaid KR. Dyspepsia. In: Feldman M, Friedman LS, Sleisenger MH, editors. Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia (PA): Saunders; 2006. p. 102-118.
19. Chiba N, Van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: The Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) ramdomised controlled trial. BMJ 2002; 324: 1012-1016.
20. Olmos JA, Pogorelsky V, Tobal F, Marcolongo M, Salis G, Higas R, et al. Uninvestigated dyspepsia in Latin America: A population-based study. Dig Dis Sci 2006; 51: 1922-1929.
21. Zarghi A, Pourhoseingholi MA, Habibi M, Nejad MR, Ramezankhani A, Zali MR. Prevalence of gastrointestinal symptoms in the population of Tehran, Iran. Trop Med Int Health 2007; 12 (Suppl); 181-182.
22. Zarghi A, Pourhoseingholi MA, Habibi M, Haghdost A, Solhpour A, Moazezi M, et al. Prevalence of gastrointestinal symptoms and the influence of demographic factors. Am J Gastroenterol 2007; 102 (Suppl): 441-441.
23. Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Solhpour A, Habibi M, et al. Gastro-oesophageal reflux disease and irritable bowel syndrome: A significant association in an Iranian population. Eur J Gastroenterol Hepatol 2008; 20: 719-725.
24. Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Habibi M, Ghafarnejad F, et al. Gastro-esophageal reflux symptoms and body mass index: No relation among the Iranian population. Indian J Gastroenterol 2008; 27: 153-155.
25. Drossman DA. Rome III: The new criteria. Chin J Dig Dis 2006; 7: 181-185.
26. Rome Foundation. Guidelines - Rome III Diagnostic Criteria for functional Gastrointestinal Disorders. J Gastrointestin Liver Dis 2006; 15: 307-312.
27. World Health Organization. Obesity Report of a WHO Consultation on Obesity. Geneva: WHO; 1998.
28. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-547.
29. Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: A global perspective. World J Gastroenterol 2006; 12: 2661-2666.
30. Lu CL, Lang HC, Chang FY Chen CY, Luo JC, Wang SS, et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: A study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol 2005; 40: 402-411.
31. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: A population-based study. Am J Gastroenterol 2002; 97; 2290-2299.
32. Li Y, Nie Y, Sha W, Su H. The link between psychosocial factors and functional dyspepsia: An epidemiological study. Chin Med J (Engl) 2002; 115: 1082-1084.
33. Curioso WH, Donaires Mendoza N, Bacilio Zerpa C, Ganoza Gallardo C, León Barúa R. [Prevalence and relation of dyspepsia to irritable bowel syndrome in a native community of the Peruvian jungle]. Rev Gastroenterol Peru 2002; 22: 129-140. (Spanish)
34. Hu WH, Wong WM, Lam CL, Lam KF, Hui WM, Lai KC, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: A population-based study. Aliment Pharmacol Ther 2002; 16: 2081-2088.
35. Van Oudenhove L. Vandenberghe J, Geeraerts B, Vos R, Persoons P, Fischler B, et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut 2008; 57: 1666-1673.
36. Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol 2004; 99: 2210-2216.
37. Delgado-Aros S, Locke GR 3rd, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, et al. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol 2004; 99: 1801-1806.
38. van Oijen MG, Josemanders DF, Laheij RJ, van Rossum LG, Tan AC, Jansen JB. Gastrointestinal disorders and symptoms: Does body mass index matter? Neth J Med 2006; 64: 45-49.